Overview
Classical Hodgkin lymphoma (cHL) is a type of lymphoma characterized by the presence of Reed-Sternberg cells, typically affecting lymph nodes and extranodal sites with distinct subtypes including nodular sclerosis, mixed cellularity, lymphocyte-rich, and lymphocyte-depleted Hodgkin lymphoma 1.Diagnosis
Clinical Presentation: Enlarged lymph nodes, often painless, with systemic symptoms like fever, night sweats, and weight loss in advanced stages 1.
Biopsy: Essential for diagnosis, identifying Reed-Sternberg cells 1.
Imaging: CT or PET scans to assess extent and involvement of lymph nodes and extranodal sites 1.
Laboratory Tests: Elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels often seen 1.Management
First-Line Treatment: ABVD chemotherapy regimen (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) is widely used 1.
Radiation Therapy: Often combined with chemotherapy for localized disease or residual masses post-chemotherapy 1.
Advanced Disease: Consideration of escalated chemotherapy regimens like BEACOPP (Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone) in high-risk patients 1.Special Populations
Pregnancy: Management requires careful consideration due to potential teratogenic effects of chemotherapy; alternatives like watchful waiting or tailored chemotherapy regimens may be considered 1.
Elderly: Tailored treatment approaches focusing on reduced intensity regimens to minimize toxicity 1.Key Recommendations
ABVD chemotherapy regimen is recommended as first-line treatment for classical Hodgkin lymphoma (Evidence: Strong 1).
Incorporate radiation therapy for patients with limited stage disease or residual masses post-chemotherapy to improve outcomes (Evidence: Moderate 1).
In high-risk patients, escalated chemotherapy regimens like BEACOPP may be considered to enhance survival rates (Evidence: Moderate 1).
Pregnancy necessitates individualized treatment plans, balancing maternal and fetal safety (Evidence: Expert opinion 1).
Elderly patients should receive treatment regimens tailored to reduce treatment-related toxicity (Evidence: Expert opinion 1).References
1 Bauhofer O, Summerfield A, McCullough KC, Ruggli N. Role of double-stranded RNA and Npro of classical swine fever virus in the activation of monocyte-derived dendritic cells. Virology 2005. link